1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Shedding of viable SARS-COV-2 after immunosuppressive therapy for cancer
    Research Letter

    Aydillo, T.; Gonzalez-Reiche, A. S.; Aslam, S.; van de Guchte, A.; Khan, Z.; Obla, A.; Dutta, J.; van Bakel, H.; Aberg, J.; García-Sastre, A.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Translation in amino-acid-poor environments is limited by tRNA(Gln) charging
    Journal Article

    Pavlova, N. N.; King, B.; Josselsohn, R. H.; Violante, S.; Macera, V. L.; Vardhana, S. A.; Cross, J. R.; Thompson, C. B.
    eLife (2020)

    Fulltext@MSK | Save
  • Combined JAK2 and ERK1/2 kinase inhibition as a potent therapeutic approach in myeloproliferative neoplasms
    Meeting Abstract

    Brkic, S.; Stivala, S.; Santopolo, A.; Jungius, S.; Passweg, J. R.; Tsakiris, D.; Dirnhofer, S.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • Therapeutic resistance to the novel JAK2 inhibitor CHZ868 in MPN is dependent on MEK-ERK activation and is targetable
    Meeting Abstract

    Szybinski, J.; Codilupi, T.; Wicki, A.; Yang, J. L.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Levine, R. L.; Koche, R.; Meyer, S. C.
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • Dual genetic targeting of ERK1 and ERK2 reduces the fitness of the malignant clone in myeloproliferative neoplasm mice
    Meeting Abstract

    Stivala, S.; Brkic, S.; Santopolo, A.; Dirnhofer, S.; Passweg, J. R.; Tsakiris, D.; Neel, B.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • End of therapy (18)F-FDG PET/CT for assessment of persistent bone involvement in B-cell lymphoma
    Meeting Abstract

    Michaud, L.; Nakajima, R.; Joffe, E.; Ghione, P.; Ahsanuddin, S.; Navitski, A.; Schoder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • Gut microbiota-derived propionate regulates the expression of Reg3 mucosal lectins and ameliorates experimental colitis in mice
    Journal Article

    Bajic, D.; Niemann, A.; Hillmer, A. K.; Mejias-Luque, R.; Bluemel, S.; Docampo, M.; Funk, M. C.; Tonin, E.; Boutros, M.; Schnabl, B.; more...
    Journal of Crohns & Colitis (2020)

    Fulltext@MSK | Save
  • Spontaneous remission in a patient with acute myeloid leukemia leading to undetectable minimal residual disease
    Journal Article

    Helbig, D.; Quesada, A. E.; Xiao, W.; Roshal, M.; Tallman, M. S.; Knorr, D. A.
    Journal of Hematology (2020)

    Fulltext@MSK | Save
  • Tebentafusp, a TCR/anti-CD3 bispecific fusion protein targeting gp100, potently activated antitumor immune responses in patients with metastatic melanoma
    Journal Article

    Middleton, M. R.; McAlpine, C.; Woodcock, V. K.; Corrie, P.; Infante, J. R.; Steven, N. M.; Evans, T. R. J.; Anthoney, A.; Shoushtari, A. N.; Hamid, O.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Cryopreservation for all is no option in unrelated stem cell transplantation. Comment on Dholaria B, et al. Securing the graft during pandemic: Are we ready for cryopreservation for all? Biol Blood Marrow Transplant. 2020;26:e145-e146
    Correspondence

    Schmidt, A. H.; Buk, D.; Platz, A.; van den Brink, M. R. M.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save